The onset of Covid-19 and the worldwide response to the pandemic has placed a spotlight on the biopharmaceutical industry and its manufacturing challenges. Today, US biopharma manufacturing lags behind other industries in the implementation of automation technology, robotics and automated quality control systems. These technologies have driven ever increasing standards for efficiency, productivity & quality in manufacturing world-wide for over 20 years.
A recent study published by McKenzie & Company
…read more on the link below
The full McKenzie & Company article is available at https://conta.cc/39ulPCT
